Migraine frequency and its association with dyslipidemia in women

Janoska, Marlena; Chorążka, Kamil; Domitrz, Izabela

doi:10.1016/j.pjnns.2015.02.001

Cited by 17 publications

(13 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, a new CM diagnosis code may be a result of a decision to consider initiation of onabotulinumtoxin A treatment, which is more likely to occur by a neurologist. In this study, comorbidities such as hypertension, dyslipidemia, anxiety, and depression showed either slightly lower risk of progression or no significant association, which appears to be inconsistent with other research that show an increased risk [28][29][30][31][32] . However it should be interpreted in the context that the regression model also included migraine medications that could also be used to treat these comorbidities, and these medication variables might modify the effect of the comorbidity on migraine progression.…”

Section: Discussioncontrasting

confidence: 99%

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Foster

Chen

Ding

et al. 2020

Journal of Medical Economics

View full text Add to dashboard Cite

Aims: To evaluate the prevalence and risk factors of migraine progression and to assess the incremental burden of migraine progression on healthcare systems. Materials and methods: Adult patients were required to have a migraine diagnosis in IQVIA's US adjudicated claims database between 1 January 2012 and 30 June 2016, continuous enrollment !12 months before and after the index date (i.e. the first observed migraine diagnosis), and !1 additional migraine diagnosis claim during the 12-month post-index period. A previously-developed algorithm identified patients with prevention-eligible episodic migraine (EM). All-cause healthcare resource utilization (HCRU) and costs were evaluated at baseline, over the follow-up period and pre/post progression from prevention-eligible EM to chronic migraine. Cox proportional hazards models were used to evaluate risk factors associated with progression. Results, limitations, and conclusions: Of the 125,436 patients with prevention-eligible EM that were initially identified, 5,790 (4.6%) were further identified as progressed. Patients who progressed had higher healthcare costs and higher medication use at baseline compared to patients that did not progress. Mean

show abstract

Section: Discussioncontrasting

confidence: 99%

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Foster

Chen

Ding

et al. 2020

Journal of Medical Economics

View full text Add to dashboard Cite

show abstract

“…Some recent studies have suggested that the intensity and frequency of migraine attacks may be related to the level of blood lipids. [232425] The mentioned issues emphasize the importance of further studying the association of these metabolic disorders as controllable risk factors for cardiovascular disorders.…”

Section: Discussionmentioning

confidence: 99%

Frequency of dyslipidemia in migraineurs in comparison to control group

Assarzadegan

Hosseinpanahi

Hesami

et al. 2019

J Family Med Prim Care

View full text Add to dashboard Cite

Background: Migraine is a common disease with neurovascular nature, which is commonly prevalent in the general population. Due to the significant prevalence of migraine and its long-term complications, it is necessary to pay attention to its exacerbating factors. Therefore, the aim of this study was to evaluate the frequency distribution of dyslipidemia in patients with migraine compared with control group. Materials and Methods: This is a case–control study, in which 50 patients with migraine (with aura and without aura) were confirmed by the criteria of International Headache Society. Migraineurs and control group ( n = 50) were selected from among patients who referred to the Neurology Clinic of Imam Hossein Hospital. The levels of total cholesterol, triglyceride, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol were measured in both the groups. SPSS software (version 21) was used to analyze the data. Results: The findings showed that among migraineurs, 21 patients (42%) revealed high levels of cholesterol and 22 revealed high levels of LDL (44%); whereas among subjects without migraine, 12 subjects (24%) exhibited high levels of cholesterol and 12 (24%) high levels of LDL, where a significant correlation between the two groups was achieved. Conclusion: The present results showed that migraine is associated with higher level of cholesterol and LDL when compared with the control group, where a significant relationship was found.

show abstract

“…In our analysis, the associations with dietary fat were driven by SFA and MUFA intake, whereas PUFA intake did not appear to play a role. Further, studies with middle-aged adults have revealed significant associations between total cholesterol and/or triglyceride concentrations and migraine [ 28 , 29 ], while research on the link between lipids, lipoprotein subfractions, and migraine has demonstrated that the worst lipid profile is underscored by the highest concentrations of triglyceride-rich lipoprotein cholesterol. It also associated cholesterol-rich remnants in both male and female migraineurs [ 30 ].…”

Section: Discussionmentioning

confidence: 99%

Macronutrient Intake in Relation to Migraine and Non-Migraine Headaches

et al. 2018

View full text Add to dashboard Cite

We investigated the association of mean daily macronutrient intake with migraine and non-migraine headaches. This cross-sectional study included 8042 men and 23,728 women from the ongoing population-based NutriNet-Santé e-cohort. Headache status was assessed via an online self-report questionnaire (2013–2016). Migraine was defined using established criteria and dietary macronutrient intake was estimated via ≥3 24 h dietary records. Mean daily intake (g/day) of carbohydrates (simple, complex, and total), protein, and fat (saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, and total) were the main exposure variables. Adjusted gender-specific analysis of variance (ANOVA) models were fit. Presence of migraines was noted in 9.2% of men (mean age = 54.3 ± 13.3 years) and 25.7% of women (mean age = 49.6 ± 12.8 years). In adjusted models, we observed (1) somewhat lower protein (p < 0.02) and higher total fat (p < 0.01) intake among male migraineurs compared with males without headaches and those with non-migraine headaches; (2) somewhat higher total fat (p < 0.0001) and total carbohydrate intake (p < 0.05) among female migraineurs compared with females without headaches and those with non-migraine headaches. The findings, which provide preliminary support for modest gender-specific differences in macronutrient intake by migraine status, merit confirmation in different population-based settings, as well as longitudinally, and could help to inform future dietary interventions in headache prevention.

show abstract

Migraine frequency and its association with dyslipidemia in women

Abstract: TC and TG values may have an influence on migraine severity and also contribute to the increased risk of cardiovascular diseases, especially in women.

Cited by 17 publications

References 18 publications

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Frequency of dyslipidemia in migraineurs in comparison to control group

Macronutrient Intake in Relation to Migraine and Non-Migraine Headaches

Contact Info

Product

Resources

About